HydroxyureaTherapy in Patients with Sickle Cell Disease

Al-Anazi KA^*

Consultant Hemato-Oncologist,Section of Adult Hematology and Oncology, Department of Medicine, College of Medicine and King Khalid University Hospital, King Saud University, Saudi Arabia

^*Corresponding Author: Al-Anazi KA, Consultant Hemato-Oncologist,Section of Adult Hematology and Oncology, Department of Medicine, College of Medicine and King Khalid University Hospital, King Saud University, P.O. Box: 2925, Riyadh 11461, Saudi Arabia, Fax: 966 - 011- 4671546 Email: